文献速递乳腺乳腺X线MRUSPET

乳腺癌检测方法:跨多站点医疗企业5年结果

Breast Cancer Method of Detection: 5-Year Outcomes Across a Multisite Health Care Enterprise.
PubMed 文献 · J Am Coll Radiol · 2024-01-02

本研究在覆盖美国四州18个影像站点的医疗企业中回顾性观察放射科医生在图像引导乳腺活检时按标准化模板归类检测方法(MOD)的可行性与准确性。共分析29,999例活检,98.1%报告了MOD且持续率随时间改善;人工复核100例中原始MOD与作者赋值一致率87%(95%CI 80.4%-93.6%)。结论认为美国放射科医生能在较长时间内一致且准确地归类MOD。

要点

  • 标准化模板可使98.1%的图像引导乳腺活检报告包含检测方法(MOD)。
  • MOD类别以乳房X线摄影最多(51.6%),其次为MRI(15.5%)和超声(11.8%)。
  • 人工复核100例中MOD原始赋值与作者赋值一致率为87%(95%CI 80.4%-93.6%)。

核心结论

  • 美国放射科医生能够在较长时间内跨医疗企业一致且准确地归类乳腺活检的检测方法(MOD)。

研究设计与样本

  • 回顾性观察研究,覆盖美国四州18个影像站点,分析2017年10月31日至2023年7月6日实施含MOD标准化模板后的所有图像引导乳腺活检,共29,999例,并随机抽取活检报告人工复核以评估MOD归类准确性。

诊断标准与关键数值

  • MOD定义为触发后续检查和活检推荐的首个检查、体征或症状;10类MOD分布为乳房X线摄影15,184例(51.6%)、MRI 4,561例(15.5%)、超声3,473例(11.8%)、自检2,382例(8.1%)、断层合成2,073例(7.0%)、临床检查432例(1.5%)、分子乳腺成像421例(1.4%)、其他检查357例(1.2%)、对比增强数字乳腺摄影338例(1.1%)、PET 202例(0.7%);人工复核100例中原始MOD与作者赋值一致率87%(95%CI 80.4%-93.6%)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To investigate the feasibility and accuracy of radiologists categorizing the method of detection (MOD) when performing image-guided breast biopsies.

METHODS: This retrospective, observational study was conducted across a health care enterprise that provides breast imaging services at 18 imaging sites across four US states. Radiologists used standardized templates to categorize the MOD, defined as the first test, sign, or symptom that triggered the subsequent workup and recommendation for biopsy. All image-guided breast biopsies since the implementation of the MOD-inclusive standardized template-from October 31, 2017 to July 6, 2023-were extracted. A random sample of biopsy reports was manually reviewed to evaluate the accuracy of MOD categorization.

RESULTS: A total of 29,999 biopsies were analyzed. MOD was reported in 29,423 biopsies (98.1%) at a sustained rate that improved over time. The 10 MOD categories in this study included the following: 15,184 mammograms (51.6%); 4,561 MRIs (15.5%); 3,473 ultrasounds (11.8%); 2,382 self-examinations (8.1%); 2,073 tomosynthesis studies (7.0%); 432 clinical examinations (1.5%); 421 molecular breast imaging studies (1.4%); 357 other studies (1.2%); 338 contrast-enhanced digital mammograms (1.1%); and 202 PET studies (0.7%). Original assignments of the MOD agreed with author assignments in 87% of manually reviewed biopsies (n = 100, 95% confidence interval: [80.4%, 93.6%]).

CONCLUSIONS: This study demonstrates that US radiologists can consistently and accurately categorize the MOD over an extended time across a health care enterprise.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Zhu A, Patel BK, Khurana A, et al. Breast Cancer Method of Detection: 5-Year Outcomes Across a Multisite Health Care Enterprise. J Am Coll Radiol. 2024. PMID: 38176672. doi:10.1016/j.jacr.2023.12.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。